Literature DB >> 21414847

Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.

Evelyn Pau1, Nan-Hua Chang, Christina Loh, Ginette Lajoie, Joan E Wither.   

Abstract

New Zealand Black (NZB) mice spontaneously develop a lupus-like autoimmune disease. Since CD40-CD40L interactions are important for B cell class-switch recombination and germinal center formation, we sought to understand the impact of these interactions on the immune abnormalities in NZB CD40L gene-deleted (CD40L(-/-)) mice in vivo. NZB.CD40L(-/-) mice demonstrated abrogation of all IgG autoantibodies tested and attenuated kidney disease. However, polyclonal B cell activation in vivo and B cell proliferation and class-switching in response to TLR ligands in vitro were preserved in the absence of CD40L in NZB mice. Although, plasmacytoid dendritic cell expansion and elevated BAFF production were unaffected by the absence of CD40L, there was some evidence that IFN-α-induced gene expression was reduced in the bone marrow of NZB.CD40L(-/-) mice. Our results suggest that CD40-CD40L interactions play an important role in promoting pathogenic IgG autoantibody production and kidney disease in NZB mice.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414847     DOI: 10.1016/j.clim.2011.02.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

1.  Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus.

Authors:  Faith M Strickland; Anura Hewagama; Qianjian Lu; Ailing Wu; Robert Hinderer; Ryan Webb; Kent Johnson; Amr H Sawalha; Colin Delaney; Raymond Yung; Bruce C Richardson
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

2.  Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity.

Authors:  Elizabeth R Walsh; Prapaporn Pisitkun; Elisaveta Voynova; Jonathan A Deane; Bethany L Scott; Rachel R Caspi; Silvia Bolland
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

Review 3.  Gonadal steroids and humoral immunity.

Authors:  Sanaz Sakiani; Nancy J Olsen; William J Kovacs
Journal:  Nat Rev Endocrinol       Date:  2012-11-27       Impact factor: 43.330

4.  T cell and dendritic cell abnormalities synergize to expand pro-inflammatory T cell subsets leading to fatal autoimmunity in B6.NZBc1 lupus-prone mice.

Authors:  Nafiseh Talaei; Yui-Ho Cheung; Carolina Landolt-Marticorena; Babak Noamani; Timothy Li; Joan E Wither
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

5.  The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus.

Authors:  Jian-Ming Chen; Jing Guo; Chuan-Dong Wei; Chun-Fang Wang; Hong-Cheng Luo; Ye-Sheng Wei; Yan Lan
Journal:  BMC Genet       Date:  2015-10-16       Impact factor: 2.797

6.  Multiple tolerance defects contribute to the breach of B cell tolerance in New Zealand Black chromosome 1 congenic mice.

Authors:  Nan-Hua Chang; Kieran P Manion; Christina Loh; Evelyn Pau; Yuriy Baglaenko; Joan E Wither
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

7.  TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice.

Authors:  Evelyn Pau; Yui-Ho Cheung; Christina Loh; Ginette Lajoie; Joan E Wither
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

8.  CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study.

Authors:  Anthony Shock; Linda Burkly; Ian Wakefield; Christopher Peters; Ellen Garber; Janine Ferrant; Frederick R Taylor; Lihe Su; Yen-Ming Hsu; David Hutto; Ali Amirkhosravi; Todd Meyer; John Francis; Sarah Malcolm; Martyn Robinson; Derek Brown; Stevan Shaw; Roland Foulkes; Alastair Lawson; Olivier Harari; Timothy Bourne; Alison Maloney; Neil Weir
Journal:  Arthritis Res Ther       Date:  2015-09-03       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.